Select Publications
Journal articles
2022, '2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action', Journal of Human Hypertension, 37, http://dx.doi.org/10.1038/s41371-022-00690-0
,2022, 'Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials', Heart, 108, pp. 1281 - 1289, http://dx.doi.org/10.1136/heartjnl-2021-320171
,2022, 'Clinical utility of KidneyIntelX in early stages of diabetic kidney disease in the CANVAS trial', American Journal of Nephrology, 53, pp. 21 - 31, http://dx.doi.org/10.1159/000519920
,2022, 'Erratum: Vital Signs During the COVID-19 Outbreak: A Retrospective Analysis of 19,960 Participants in Wuhan and Four Nearby Capital Cities in China (Global Heart (2021) 16: 1 (47) DOI: 10.5334/gh.913)', Global Heart, 17, pp. 88, http://dx.doi.org/10.5334/GH.1172
,2022, 'Randomized Trials Fit for the 21st Century. A Joint Opinion from the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation', Global Heart, 17, pp. 85, http://dx.doi.org/10.5334/GH.1178
,2022, 'Abstract P201: Canagliflozin, Visit-to-visit Blood Pressure Variability, And Risk Of Cardiovascular, Kidney, And Mortality Outcomes: Pooled Individual Participant Data From The CANVAS And CREDENCE Trials', Hypertension, 79, http://dx.doi.org/10.1161/hyp.79.suppl_1.p201
,2022, 'Testing the Feasibility and Dietary Impact of a "Produce Prescription" Program for Adults with Undermanaged Type 2 Diabetes and Food Insecurity in Australia.', J Nutr, 152, pp. 2409 - 2418, http://dx.doi.org/10.1093/jn/nxac152
,2021, 'Salt Substitute and Cardiovascular Events and Death. Reply', The New England journal of medicine, 385, pp. 2493 - 2494, http://dx.doi.org/10.1056/NEJMc2116824
,2021, 'Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: The CREDENCE trial', European Heart Journal, 42, pp. 4891 - 4901, http://dx.doi.org/10.1093/eurheartj/ehab497
,2021, 'Factors Associated with the Use of a Salt Substitute in Rural China', JAMA Network Open, 4, pp. e2137745, http://dx.doi.org/10.1001/jamanetworkopen.2021.37745
,2021, 'Association between circulating gdf-15 and cardio-renal outcomes and effect of canagliflozin: Results from the canvas trial', Journal of the American Heart Association, 10, pp. e021661, http://dx.doi.org/10.1161/JAHA.121.021661
,2021, 'Drawing on Strategic Management Approaches to Inform Nutrition Policy Design: An Applied Policy Analysis for Salt Reduction in Packaged Foods', International journal of health policy and management, 10, pp. 896 - 908, http://dx.doi.org/10.34172/ijhpm.2020.204
,2021, 'Estimating the potential impact of the Australian government’s reformulation targets on household sugar purchases', International Journal of Behavioral Nutrition and Physical Activity, 18, pp. 138, http://dx.doi.org/10.1186/s12966-021-01208-6
,2021, 'Protocol for a randomized controlled trial to test the acceptability and adherence to 6-months of walnut supplementation in Chinese adults at high risk of cardiovascular disease', Nutrition Journal, 20, pp. 3, http://dx.doi.org/10.1186/s12937-020-00660-7
,2021, 'Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm', Trials, 22, pp. 962, http://dx.doi.org/10.1186/s13063-021-05915-0
,2021, 'Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis', Diabetes, Obesity and Metabolism, 23, pp. 2707 - 2715, http://dx.doi.org/10.1111/dom.14525
,2021, 'The relative importance of primary food choice factors among different consumer groups: A latent profile analysis', Food Quality and Preference, 94, pp. 104199, http://dx.doi.org/10.1016/j.foodqual.2021.104199
,2021, 'Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA
2021, 'Heart failure therapies for the prevention of her2-monoclonal antibody-mediated cardiotoxicity: A systematic review and meta-analysis of randomized trials', Cancers, 13, pp. 5527, http://dx.doi.org/10.3390/cancers13215527
,2021, 'The impact of baseline potassium intake on the dose–response relation between sodium reduction and blood pressure change: systematic review and meta-analysis of randomized trials', Journal of Human Hypertension, 35, pp. 946 - 957, http://dx.doi.org/10.1038/s41371-021-00510-x
,2021, 'Projected effects on salt purchases following implementation of a national salt reduction policy in South Africa', Public Health Nutrition, 24, pp. 4614 - 4621, http://dx.doi.org/10.1017/S1368980020005273
,2021, 'Effects of canagliflozin on hyperkalaemia and serum potassium in people with diabetes and chronic kidney disease: insights from the CREDENCE trial', European Heart Journal, 42, pp. ehab724.2647, http://dx.doi.org/10.1093/eurheartj/ehab724.2647
,2021, 'Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial', Diabetologia, 64, pp. 2147 - 2158, http://dx.doi.org/10.1007/s00125-021-05512-5
,2021, 'The estimated health impact of sodium reduction through food reformulation in Australia: A modeling study', PLoS Medicine, 18, pp. e1003806, http://dx.doi.org/10.1371/journal.pmed.1003806
,2021, 'The role of sodium glucose cotransporter-2 inhibitors in atherosclerotic cardiovascular disease: A narrative review of potential mechanisms', Cells, 10, pp. 2699, http://dx.doi.org/10.3390/cells10102699
,2021, 'Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis', The Lancet, 398, pp. 1053 - 1064, http://dx.doi.org/10.1016/S0140-6736(21)01921-8
,2021, 'Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial', The Lancet, 398, pp. 1043 - 1052, http://dx.doi.org/10.1016/S0140-6736(21)01922-X
,2021, 'Effect of Salt Substitution on Cardiovascular Events and Death', New England Journal of Medicine, 385, pp. 1067 - 1077, http://dx.doi.org/10.1056/NEJMoa2105675
,2021, 'A Systematic Review of Salt Reduction Initiatives around the World: A Midterm Evaluation of Progress towards the 2025 Global Non-Communicable Diseases Salt Reduction Target', Advances in Nutrition, 12, pp. 1768 - 1780, http://dx.doi.org/10.1093/advances/nmab008
,2021, 'Barriers and facilitators to implementing reduced-sodium salts as a population-level intervention: A qualitative study', Nutrients, 13, pp. 3225, http://dx.doi.org/10.3390/nu13093225
,2021, 'Healthy Food Prescription Programs and their Impact on Dietary Behavior and Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis', Advances in Nutrition, 12, pp. 1944 - 1956, http://dx.doi.org/10.1093/advances/nmab039
,2021, 'Protocol for the economic evaluation of the China Salt Substitute and Stroke Study (SSaSS)', BMJ Open, 11, pp. e045929, http://dx.doi.org/10.1136/bmjopen-2020-045929
,2021, 'Association of Baseline Diuretic Use With Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction: A Secondary Analysis From TOPCAT', Journal of Cardiac Failure, 27, pp. 816 - 818, http://dx.doi.org/10.1016/j.cardfail.2021.02.010
,2021, 'Availability, formulation, labeling, and price of low-sodium salt worldwide: Environmental scan', JMIR Public Health and Surveillance, 7, pp. e27423, http://dx.doi.org/10.2196/27423
,2021, 'Canagliflozin, serum magnesium and cardiovascular outcomes—Analysis from the CANVAS Program', Endocrinology, Diabetes and Metabolism, 4, pp. e00247, http://dx.doi.org/10.1002/edm2.247
,2021, 'Effects of a reduced-sodium added-potassium salt substitute on blood pressure in rural Indian hypertensive patients: A randomized, double-blind, controlled trial', American Journal of Clinical Nutrition, 114, pp. 185 - 193, http://dx.doi.org/10.1093/ajcn/nqab054
,2021, 'Influence of sugar label formats on consumer understanding and amount of sugar in food choices: A systematic review and meta-analyses', Nutrition Reviews, 79, pp. 788 - 801, http://dx.doi.org/10.1093/nutrit/nuaa108
,2021, 'Measuring the healthiness of ready-to-eat child-targeted cereals: Evaluation of the FoodsWitch platform in Sweden', JMIR mHealth and uHealth, 9, pp. e17780, http://dx.doi.org/10.2196/17780
,2021, 'Deconstructing the supermarket: Systematic ingredient disaggregation and the association between ingredient usage and product health indicators for 24,229 australian foods and beverages', Nutrients, 13, pp. 1882, http://dx.doi.org/10.3390/nu13061882
,2021, 'Feasibility and validity of using death surveillance data and SmartVA for fact and cause of death in clinical trials in rural China: A substudy of the China salt substitute and stroke study (SSaSS)', Journal of Epidemiology and Community Health, 75, pp. 540 - 549, http://dx.doi.org/10.1136/jech-2020-214063
,2021, 'The adaptation, validation, and application of a methodology for estimating the added sugar content of packaged food products when total and added sugar labels are not mandatory', Food Research International, 144, pp. 110329, http://dx.doi.org/10.1016/j.foodres.2021.110329
,2021, 'Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE Trial', Circulation, 143, pp. 1735 - 1749, http://dx.doi.org/10.1161/CIRCULATIONAHA.120.048740
,2021, 'Budget impact and cost-effectiveness analyses of the COBRA-BPS multicomponent hypertension management programme in rural communities in Bangladesh, Pakistan, and Sri Lanka', The Lancet Global Health, 9, pp. e660 - e667, http://dx.doi.org/10.1016/S2214-109X(21)00033-4
,2021, 'Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: Results from the CREDENCE trial and meta-analysis', Stroke, 52, pp. 1545 - 1556, http://dx.doi.org/10.1161/STROKEAHA.120.031623
,2021, 'Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis', The Lancet, 397, pp. 1625 - 1636, http://dx.doi.org/10.1016/S0140-6736(21)00590-0
,2021, 'Prospective associations of the original Food Standards Agency nutrient profiling system and three variants with weight gain, overweight and obesity risk: Results from the French NutriNet-Santé cohort', British Journal of Nutrition, 125, pp. 902 - 914, http://dx.doi.org/10.1017/S0007114520003384
,2021, 'Sodium, Blood Pressure, and the Likely Massive Avoidable Burden of Cardiovascular Disease', Circulation, 143, pp. 1568 - 1570, http://dx.doi.org/10.1161/CIRCULATIONAHA.120.052654
,2021, 'Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial', Cardiovascular Research, 118, pp. 1103 - 1114, http://dx.doi.org/10.1093/cvr/cvab128
,2021, 'Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis', The Lancet Oncology, 22, pp. 558 - 570, http://dx.doi.org/10.1016/S1470-2045(21)00033-4
,2021, 'Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program', ESC Heart Failure, 8, pp. 1482 - 1493, http://dx.doi.org/10.1002/ehf2.13236
,